Since active scavenging of ROS is associated with glioma stem cell resistance to radiation and chemotherapy, the interplay between TRAP1 and SIRT3 may contribute to the therapeutic resistance of cancer stem cells in vivo. This evidence concerns the gene SIRT3 and central nervous system cancer.